Lubiprostone
17482
Unknown small_molecule completed
Quick answer
Lubiprostone for Constipation-predominant Irritable Bowel Syndrome is a Unknown program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Constipation-predominant Irritable Bowel Syndrome
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed